Charles Schwab Investment Management Inc Immunity Bio, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,236,316 shares of IBRX stock, worth $4.27 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,236,316
Previous 1,171,212
5.56%
Holding current value
$4.27 Million
Previous $6.29 Million
24.23%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding IBRX
# of Institutions
216Shares Held
63.3MCall Options Held
1.43MPut Options Held
4.12M-
Vanguard Group Inc Valley Forge, PA13.8MShares$47.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$39.4 Million0.0% of portfolio
-
State Street Corp Boston, MA7.86MShares$27.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.92MShares$13.5 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY1.72MShares$5.92 Million0.01% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.38B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...